Optus Pharmaceutical Co Ltd
KOSDAQ:131030
Relative Value
The Relative Value of one Optus Pharmaceutical Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 11 910 KRW, Optus Pharmaceutical Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Optus Pharmaceutical Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
O
|
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
|
210.2B KRW | 2.5 | 22.1 | 13.6 | 20.6 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.4T JPY | 10.3 | 37.5 | 27.2 | 32.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
56.1B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
28.8B CHF | 3.5 | 37.4 | 14.4 | 28 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
95.5B DKK | 3.5 | 24.1 | 12.8 | 15.2 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.4B USD | 3.1 | 30.1 | 12.9 | 17.8 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 2.4 | 32.9 | 11.5 | 18 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 1.1 | -15.4 | 16.8 | 54.3 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
39.4B CNY | 8.7 | 23.9 | 21.5 | 21.5 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
38.8B CNY | 3.9 | 22.8 | 34 | 34 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
836.8B JPY | 6.4 | 47.3 | 22.3 | 30.3 |